Navigation Links
Hologic to Present at the Citigroup Investment Research Global Healthcare Conference
Date:5/15/2008

BEDFORD, Mass., May 15 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) today announced that Glenn Muir, Chief Financial Officer, will be presenting at the Citigroup Investment Research Global Healthcare Conference being held May 21 - 22, 2008, at the Hilton Hotel in New York, NY.

Interested parties are invited to listen to a live audio webcast of Hologic's investor presentation on Thursday, May 22, 2008, at 3:00 p.m., Eastern Time on the investor section of the Company's website at http://www.hologic.com/investor. An archive of the presentation will be available for replay following the conference.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic leads the industry in digital mammography systems and offers the most advanced technology for breast imaging and breast biopsy. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, and mini C-arm for extremity imaging. For more information visit http://www.hologic.com.

Contact: Glenn P. Muir Frances Doria

Executive Vice President & CFO Director, Investor Relations

Hologic, Inc. Hologic, Inc.

(781) 999-7300 (781) 999-7377


'/>"/>
SOURCE Hologic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Hologic to Present at the Bank of America Healthcare Conference
2. Hologic, Inc. to Release Second Quarter Fiscal 2008 Operating Results Thursday, May 1st Before Market Opens
3. Hologic to Present at the Sun Trust Robinson Humphreys 37th Annual Institutional Conference
4. Hologic Announces First Quarter Fiscal 2008 Operating Results
5. Hologic to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Hologic, Inc. to Release First Quarter Fiscal 2008 Operating Results Thursday, January 31st Before Market Opens
7. Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress
8. Modigene to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
9. Cell Therapeutics, Inc. (CTI) to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
10. Sigma-Aldrich to Present at the Nasdaq 21st Investor Program on Wednesday, May 21, 2008
11. AEterna Zentaris to Present at Upcoming Rodman & Renshaw Global Healthcare Conference and AUA Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , Health care employmen...emains the only one to show consistent growth duri...lty hospitals remain in trouble, and health system...cal personnel, instead of just administrators. , ...-- Health care employment continued growing in Oct...
(Date:11/24/2009)... ,, SEATTLE,Nov.24/PRNewswire/--BlueMarbleEn...ublicDevelopmentAuthority(OPDA)wererecentlyawarded...alizationBoard(CERB)inaprivate/publicpartnershipto...ineryinLincolnCounty,WA. ,, "Thisinvestmentwill...dbringover70greenjobstoLincolnCounty,"saidBlueMarb...
(Date:11/24/2009)... ,, SANDIEGO,Nov.24,2009/PRNewswire-FirstCal...ced todaythatthecompanyisscheduledtopresentattheP...r1,2009at11:30a.m.EasternTime(8:30a.m.PacificTime)...a,s President andChiefExecutiveOfficer,isscheduled...aldevelopmentanddiscoveryprograms. ,, Aliveaudi...
(Date:11/24/2009)... ,, SEATTLE,Nov.24/PRNewswire-FirstCall/--Ce...entwillpresentatthe21stAnnualPiperJaffrayHealthCar...9,attheNewYorkPalaceHotel. ,, CTIwillpresentonT...hFloor).AliveaudiowebcastofCTI,spresentationwillbe...obeavailableforreplayafterwards. , ,PiperJaffrayH...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...nsional liquid chromatography (MDLC) • revers...MS/MS • DeCyder MS • differential analys...n conjunction with tandem mass spectrometry (MS/MS...racted from the pollen of the olive tree, Olea eu...oftware (DeCyder MS) was used to quantitate differ...
... DNA Genotek Inc., Ottawa, ON, Canada , ...l with TaqMan SNP Genotyping Assays. , SN...n E genes were reliably , detected., ...nucleotide polymorphisms (SNPs) are highly abundan...of every 1,000 bases in the human genome (ref. 1)....
... Ottawa, Ontario, Canada , , St...n add significant , costs to a project. O..., specimens to be stored for years at room..., , Introduction , L...to thousands of subjects, , are frequentl...
Other Biology Technology:Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 2Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 3Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 4Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 5Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 6Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 7Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 8Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 9Oragene is compatible with TaqMan SNP genotyping 2Oragene is compatible with TaqMan SNP genotyping 3DNA Stability with Oragene 2DNA Stability with Oragene 3
(Date:11/23/2009)... CHAMPAIGN, Ill. A new study provides "incontrov... of Toba on the island of Sumatra about 73,000 yea...0 miles from the epicenter, researchers report. ,...eters of ash into the atmosphere, leaving a crater...00 kilometers long and 35 kilometers wide. Ash fro...
(Date:11/23/2009)..., BIRMINGHAM, Ala. A new study by University of...t body-mass index (BMI) and co-existing medical co...ed survival observed among African-Americans compa...study is published online Nov. 23 in Cancer , a j...ding indicates that although BMI and co-morbidity ...
(Date:11/23/2009)...CORVALLIS, Ore. A string of recent discoveries ab...renewed interest in this multi-purpose nutrient, i...ho are deficient in it, spurred research and even ...ic." , On issues ranging from the health of your...even vulnerability to influenza, vitamin D is now ...
Breaking Biology News(10 mins):Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3Diamyd 28R 29 Phase III Study Approved for Younger Patients in the US 12511 1Diamyd 28R 29 Phase III Study Approved for Younger Patients in the US 12511 2Photos 3A FDA Approves 12 Month Labeling Update for EVOLENCE 28R 29 Collagen Based Facial Filler 12508 1Photos 3A FDA Approves 12 Month Labeling Update for EVOLENCE 28R 29 Collagen Based Facial Filler 12508 2Photos 3A FDA Approves 12 Month Labeling Update for EVOLENCE 28R 29 Collagen Based Facial Filler 12508 3Photos 3A FDA Approves 12 Month Labeling Update for EVOLENCE 28R 29 Collagen Based Facial Filler 12508 4Somanetics Corporation to Release Second Quarter 2009 Financial Results and Host Conference Call June 17 2009 48147 1Somanetics Corporation to Release Second Quarter 2009 Financial Results and Host Conference Call June 17 2009 48147 2
...the bad guys that help bacterial pathogens do thei...s immune system. In essence, they knock down the ...rm system. , Now, researchers at the University of...ave identified a novel molecular target for an eff...s of the bacteria Yersinia – the pathogen responsi...
...as found that a new gene therapy can nearly elimin...term damage to the affected joints, according to a...d Rheumatism. While the study was done in mice, th... osteoarthritis like humans, with the same genetic...elop the disease, the authors said. If all goes we...
...eered to lack a single enzyme in their brains are ...and are quicker to figure out that their environme...uthwestern Medical Center has found. , The result...ournal Nature Neuroscience , reveal a new mechani...humans as a target for treating disorders such as ...
Other Biology News:How plague-causing bacteria disarm host defense 2Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 2Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 3Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 4'Smart' mice teach scientists about learning process, brain disorders 2
Yeast-GFP 96-well Plates from Invitrogen
...joined forces with the Mickle Laboratory Engineeri...hopper. This tissue sectioning system has been des...experiments and to be especially applicable to sma...from small organs. Its special features cause much...
Earle's Balanced Salt Solution, 10x (EBSS) from Sigma-Aldrich
...ive peptides are molecules of peptidic nature or o...vity which can be developed at the industrial leve...o-food applications. In this way it is possible to... for therapeutic applications. Primm offers a desi...
Biology Products: